Albumin fusion for hemophilia
Albumin fusion is a molecular technology that has been used to create replacement therapies for hemophilia with an extended half-life — treatments that are more long-lasting in the...
Search fresh public links, source activity, and ready-to-use post angles for Albumin Fusion.
Fresh curated links around Albumin fusion are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Albumin fusion is a molecular technology that has been used to create replacement therapies for hemophilia with an extended half-life — treatments that are more long-lasting in the...
Preclinical study found that fusing immunoglobulin G (IgG) antibodies to albumin minimized antibody transport across the placenta and prevented adverse effects in offspring in mice...
Alvotech and Lotus Pharmaceutical are teaming up on plans to commercialize AVT87, a proposed biosimilar to Hemlibra (emicizumab). Lisa Graver, CEO of Alvotech, said in a company pr...
Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech up to $260 million for rights to a fusion protein in certain thymus-related indications in the Americas a...
Obizur (susoctocog alfa) is a recombinant porcine (pig-derived) factor VIII concentrate approved for the on-demand treatment of bleeds in adults with acquired hemophilia A. The pos...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.